ArticleTherapeutic advances in medical oncology2020

Biomarker testing for personalized, first-line therapy in advanced nonsquamous non-small cell lung cancer patients in the real world setting in Japan: a retrospective, multicenter, observational study (the BRAVE study).

Junichi Shimizu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.